Arcellx Inc
General ticker "ACLX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $4.6B
Arcellx Inc follows the US Stock Market performance with the rate: 61.6%.
Estimated limits based on current volatility of 2.9%: low 73.56$, high 77.98$
Factors to consider:
- Current price 16.2% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [37.11$, 66.07$]
- 2024-12-30 to 2025-12-30 estimated range: [31.61$, 58.52$]
Short-term ACLX quotes
Long-term ACLX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $110.32MM |
| Operating Expenses | $65.02MM | $191.26MM | $200.20MM |
| Operating Income | $-65.02MM | $-191.26MM | $-89.88MM |
| Non-Operating Income | $-0.01MM | $-1.72MM | $19.85MM |
| Interest Expense | $0.01MM | $1.72MM | $3.84MM |
| R&D Expense | $46.88MM | $149.56MM | $133.85MM |
| Income(Loss) | $-65.03MM | $-192.98MM | $-70.03MM |
| Taxes | $0.00MM | $0.00MM | $0.66MM |
| Profit(Loss) | $-65.03MM | $-192.98MM | $-70.69MM |
| Stockholders Equity | $-121.52MM | $204.95MM | $485.38MM |
| Assets | $128.78MM | $313.82MM | $825.13MM |
| Operating Cash Flow | $-54.24MM | $-99.30MM | $207.57MM |
| Capital expenditure | $5.78MM | $2.28MM | $21.43MM |
| Investing Cash Flow | $-79.98MM | $-117.67MM | $-154.51MM |
| Financing Cash Flow | $118.45MM | $252.62MM | $279.16MM |
| Earnings Per Share* | $-1.79 | $-4.22 | $-1.47 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.